A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104)
Titel:
A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104)
Auteur:
Goldstein, Lori J. Zhao, Fengmin Wang, Molin Swaby, Ramona F. Sparano, Joseph A. Meropol, Neal J. Bhalla, Kapil N. Pellegrino, Christine M. Katherine Alpaugh, R. Falkson, Carla I. Klein, Paula Sledge, George W.